Current with changes from the 2024 Legislative Session
Section 21-2B-03 - Actions prohibited if based on recommendation regarding access to or treatment with an investigational drug, biological product, or device(a) A health occupations board may not revoke, fail to renew, suspend, or take any action against a health care provider's license based solely on the health care provider's recommendation to an eligible patient regarding access to or treatment with an individualized investigational treatment.(b) The Department may not take action against a health care provider's Medicare certification based solely on the health care provider's recommendation that an eligible patient have access to an individualized investigational treatment or the health care provider's treatment of an eligible patient with an individualized investigational treatment.Amended by 2024 Md. Laws, Ch. 960,Sec. 1, eff. 10/1/2024.Added by 2017 Md. Laws, Ch. 771, Sec. 1, eff. 10/1/2017.